Research Paper Volume 16, Issue 6 pp 5163—5183
Novel histone acetylation-related lncRNA signature for predicting prognosis and tumor microenvironment in esophageal carcinoma
Figure 4. Validation of risk signature based on two HARlncRNAs in the TCGA cohort. (A) The heatmaps of prognostic 2 genes signature in the training set. (B) The heatmaps of prognostic 2 genes signature in the test set. (C) Risk score distribution plot showed the distribution of high-risk and low-risk LUAD patients in the training set. Scatter plot showed the correlation between the survival status and risk score of LUAD patients in the training set. (D) Risk score distribution plot showed the distribution of high-risk and low-risk LUAD patients in the test set. Scatter plot showed the correlation between the survival status and risk score of LUAD patients in the test set. The survival analysis in the training set (E) and test set (F). ROC curve analysis of the accuracy of the model to predict patient prognosis at 1, 3, and 5 years in the training (G) and test sets (H).